RYR1 Chromosome 19

Ryanodine receptor 1
1315 variants 24 Drug Response 1291 Health Risk

Upload your DNA to see your personal genotypes for variants in RYR1.

What This Gene Does
This gene encodes a ryanodine receptor found in skeletal muscle. The encoded protein functions as a calcium release channel in the sarcoplasmic reticulum but also serves to connect the sarcoplasmic reticulum and transverse tubule. Mutations in this gene are associated with malignant hyperthermia susceptibility, central core disease, and minicore myopathy with external ophthalmoplegia. Alternatively spliced transcripts encoding different isoforms have been described. [provided by RefSeq, Jul 2008]
Gene Info
Gene Group
"Ryanodine receptors|Protein phosphatase 1 regulatory subunits"
Locus Type
gene with protein product
Location
19q13.2
Ensembl
ENSG00000196218
Associated Conditions (74)
Central core myopathy
RYR1-related disorder
King Denborough syndrome
desflurane response - Toxicity
halothane response - Toxicity
enflurane response - Toxicity
isoflurane response - Toxicity
methoxyflurane response - Toxicity
sevoflurane response - Toxicity
succinylcholine response - Toxicity
RYR1-related myopathy
Malignant hyperthermia
susceptibility to
1
Congenital multicore myopathy with external ophthalmoplegia
Malignant hyperthermia of anesthesia
Congenital myopathy with fiber type disproportion
Inborn genetic diseases
Congenital myopathy
Myopathy
+54 more conditions
Key Variants
RS118192124
Likely pathogenic; drug response
Central core myopathy, RYR1-related disorder, King Denborough syndrome
Drug Response
RS121918596
Likely pathogenic; drug response
Malignant hyperthermia, susceptibility to, 1
Drug Response
RS193922748
Likely pathogenic; drug response
RYR1-related disorder, sevoflurane response - Toxicity, Malignant hyperthermia
Drug Response
RS193922762
Likely pathogenic; drug response
Malignant hyperthermia, susceptibility to, 1
Drug Response
RS193922770
Likely pathogenic; drug response
RYR1-related disorder, desflurane response - Toxicity, halothane response - Toxicity
Drug Response
RS193922818
Likely pathogenic; drug response
RYR1-related disorder, Malignant hyperthermia, susceptibility to
Drug Response
RS193922832
Likely pathogenic; drug response
RYR1-related disorder, sevoflurane response - Toxicity, desflurane response - Toxicity
Drug Response
RS193922876
Likely pathogenic; drug response
desflurane response - Toxicity, enflurane response - Toxicity, succinylcholine response - Toxicity
Drug Response
RS193922878
Likely pathogenic; drug response
desflurane response - Toxicity, halothane response - Toxicity, isoflurane response - Toxicity
Drug Response
RS28933397
Likely pathogenic; drug response
Malignant hyperthermia, susceptibility to, 1
Drug Response
RS118192122
Pathogenic; drug response
Central core myopathy, Malignant hyperthermia, susceptibility to
Drug Response
RS118192161
Pathogenic; drug response
Malignant hyperthermia, susceptibility to, 1
Drug Response
All Variants (1315)
RSID Category Clinical Significance Conditions
RS370350821 Health Risk Conflicting classifications of pathogenicity RYR1-related disorder, Congenital multicore myopathy with external ophthalmoplegia, Malignant hyperthermia
RS370469515 Health Risk Conflicting classifications of pathogenicity RYR1-related disorder, Malignant hyperthermia, susceptibility to
RS370851779 Health Risk Conflicting classifications of pathogenicity Malignant hyperthermia, susceptibility to, 1
RS370928637 Health Risk Conflicting classifications of pathogenicity Malignant hyperthermia, susceptibility to, 1
RS370966353 Health Risk Conflicting classifications of pathogenicity Congenital myasthenic syndrome, RYR1-related disorder, Congenital multicore myopathy with external ophthalmoplegia
RS370994573 Health Risk Conflicting classifications of pathogenicity RYR1-related disorder, Central core myopathy, Malignant hyperthermia
RS371047178 Health Risk Conflicting classifications of pathogenicity Central core myopathy, RYR1-related disorder, Malignant hyperthermia
RS371199096 Health Risk Conflicting classifications of pathogenicity RYR1-related disorder, RYR1-related disorder
RS371566475 Health Risk Conflicting classifications of pathogenicity Myopathy, RYR1-associated, RYR1-related disorder
RS371686683 Health Risk Conflicting classifications of pathogenicity RYR1-related disorder, RYR1-related disorder
RS371783666 Health Risk Conflicting classifications of pathogenicity RYR1-related disorder, Malignant hyperthermia, susceptibility to
RS371952058 Health Risk Conflicting classifications of pathogenicity RYR1-related disorder, Malignant hyperthermia, susceptibility to
RS372178862 Health Risk Conflicting classifications of pathogenicity RYR1-related disorder, Malignant hyperthermia, susceptibility to
RS372203483 Health Risk Conflicting classifications of pathogenicity RYR1-related disorder, Malignant hyperthermia, susceptibility to
RS372447264 Health Risk Conflicting classifications of pathogenicity RYR1-related disorder, Malignant hyperthermia, susceptibility to
RS372491219 Health Risk Conflicting classifications of pathogenicity RYR1-related disorder, Inborn genetic diseases, Malignant hyperthermia
RS372513400 Health Risk Conflicting classifications of pathogenicity RYR1-related disorder, RYR1-related disorder
RS372702492 Health Risk Conflicting classifications of pathogenicity Congenital myopathy with fiber type disproportion, Congenital multicore myopathy with external ophthalmoplegia, King Denborough syndrome
RS372730488 Health Risk Conflicting classifications of pathogenicity Malignant hyperthermia, susceptibility to, 1
RS373382967 Health Risk Conflicting classifications of pathogenicity RYR1-related disorder, Malignant hyperthermia, susceptibility to
RS373523691 Health Risk Conflicting classifications of pathogenicity RYR1-related disorder, Malignant hyperthermia, susceptibility to
RS373702420 Health Risk Conflicting classifications of pathogenicity RYR1-related disorder, Congenital myopathy with fiber type disproportion, King Denborough syndrome
RS374058542 Health Risk Conflicting classifications of pathogenicity RYR1-related disorder, Malignant hyperthermia, susceptibility to
RS374070555 Health Risk Conflicting classifications of pathogenicity RYR1-related disorder, Malignant hyperthermia of anesthesia, Malignant hyperthermia
RS374115286 Health Risk Conflicting classifications of pathogenicity RYR1-related disorder, Malignant hyperthermia, susceptibility to
RS374116226 Health Risk Conflicting classifications of pathogenicity Malignant hyperthermia, susceptibility to, 1
RS374325589 Health Risk Conflicting classifications of pathogenicity RYR1-related disorder, Central core myopathy, King Denborough syndrome
RS3745845 Health Risk Conflicting classifications of pathogenicity Congenital multicore myopathy with external ophthalmoplegia, Malignant hyperthermia, susceptibility to
RS3745846 Health Risk Conflicting classifications of pathogenicity Malignant hyperthermia, susceptibility to, 1
RS374630822 Health Risk Conflicting classifications of pathogenicity RYR1-related disorder, Malignant hyperthermia, susceptibility to
RS374924686 Health Risk Conflicting classifications of pathogenicity Congenital multicore myopathy with external ophthalmoplegia, Malignant hyperthermia, susceptibility to
RS374937694 Health Risk Conflicting classifications of pathogenicity RYR1-related disorder, Malignant hyperthermia, susceptibility to
RS375020048 Health Risk Conflicting classifications of pathogenicity RYR1-related disorder, RYR1-related disorder
RS375163703 Health Risk Conflicting classifications of pathogenicity RYR1-related disorder, Malignant hyperthermia, susceptibility to
RS375167590 Health Risk Conflicting classifications of pathogenicity RYR1-related disorder, Malignant hyperthermia, susceptibility to
RS375402078 Health Risk Conflicting classifications of pathogenicity Congenital multicore myopathy with external ophthalmoplegia, Malignant hyperthermia, susceptibility to
RS375640581 Health Risk Conflicting classifications of pathogenicity Malignant hyperthermia, susceptibility to, 1
RS375915752 Health Risk Conflicting classifications of pathogenicity Malignant hyperthermia, susceptibility to, 1
RS375997435 Health Risk Conflicting classifications of pathogenicity Congenital multicore myopathy with external ophthalmoplegia, Malignant hyperthermia, susceptibility to
RS376176332 Health Risk Conflicting classifications of pathogenicity RYR1-related disorder, RYR1-related disorder
RS376293495 Health Risk Conflicting classifications of pathogenicity RYR1-related disorder, Malignant hyperthermia, susceptibility to
RS376482004 Health Risk Conflicting classifications of pathogenicity RYR1-related disorder, Malignant hyperthermia, susceptibility to
RS376677576 Health Risk Conflicting classifications of pathogenicity Malignant hyperthermia, susceptibility to, 1
RS376687300 Health Risk Conflicting classifications of pathogenicity RYR1-related disorder, Malignant hyperthermia, susceptibility to
RS376790408 Health Risk Conflicting classifications of pathogenicity RYR1-related disorder, Inborn genetic diseases, Malignant hyperthermia
RS376790946 Health Risk Conflicting classifications of pathogenicity RYR1-related disorder, Malignant hyperthermia, susceptibility to
RS376830015 Health Risk Conflicting classifications of pathogenicity RYR1-related disorder, Inborn genetic diseases, Malignant hyperthermia
RS376851030 Health Risk Conflicting classifications of pathogenicity Congenital multicore myopathy with external ophthalmoplegia, Malignant hyperthermia, susceptibility to
RS377178986 Health Risk Conflicting classifications of pathogenicity Congenital myopathy, RYR1-related disorder, Malignant hyperthermia
RS377282283 Health Risk Conflicting classifications of pathogenicity Malignant hyperthermia, susceptibility to, 1
« Prev 1 ... 6 7 8 9 10 11 12 ... 27 Next »
Sign Up to Analyze Your DNA Log In